🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

The best thing about MD Anderson Cancer Center? The amazing mentorship and support from faculty and peers in our mission to #endcancer #ASH23 Sanam Loghavi, MD صنم لغوی 🔬🧬 Hima Atluri, MD Georgina Gener Guillermo Montalban-Bravo Tapan Kadia G Garcia-Manero Nitin Jain Naveen Pemmaraju, MD Hagop Kantarjian,MD

Large retrospective JAK2-mut myelofibrosis cohort from MD Anderson Cancer Center by Julie Braish ➡️ JAK2 allele frequency does not predict OS ➡️ Myelodepletive phenotype leads to worse survival ➡️ Both myelodepletive and myeloproliferative MF have ⬆️ OS from ruxolitinib #MPNsm #ASCO24

How do cytopenias, proliferation and JAK2 allele burden impact the outcome of patients with myelofibrosis? Our fellow Dr. Julie Braish shared findings (Abstract 6514) at #ASCO24. Learn more: bit.ly/3V4biEY Julie Braish ASCO #EndCancer

🏆Congratulations Julie Braish from MD Anderson Cancer Center on your oral presentation at #ASCO24 showing that cytopenias and/or proliferation, rather than JAK2 </≥50%, define the outcome of PMF and PPV/PET-MF patients‼️ #leusm OncoAlert Full details below⬇️⬇️ meetings.asco.org/abstracts-pres…

Mentoring is the most rewarding in academia 💫. Super proud mentor moment & BIG Congratulations 👏 🎉 to Julie Braish for amazing presentation and your hard work to further define relevant features for #MF #MPNSM outcome!! #ASCO24 MD Anderson Cancer Center

Our Dr. Lucia Masarova showcased a Phase Ib study of add-on therapy with CK0804 in people with myelofibrosis and suboptimal response to ruxolitinib at #ASCO24. Lucia Masarova, MD and team are pioneering this kind of approach for myelofibrosis, and the study is currently enrolling. ASCO

Grateful for good friends and great mentors #womeninmedicine

Leukemia fellowship graduation MD Anderson Cancer Center! Great night with awesome friends 🤩!

It is so rewarding to be able to mentor and watch growing smart passionate doctors like Julie Braish. Congrats to your presentations at #MPNCongress23 #ASH23 and #ASCO24 and becoming Chief Fellow #Leuksm MD Anderson Cancer Center. So well deserved 👏👏!!!

A recent study reviewed both established and emerging prognostic markers in chronic lymphocytic leukemia and their role in predicting disease, treatment response and overall survival. Read more: bit.ly/3KSukJR @braishjulie #CLL #EndCancer

We interviewed Julie Braish, a leukemia fellow at MD Anderson Cancer Center, about her study on the impact of JAK2 allele burden in patients with #myelofibrosis at #ASCO24! ➡️ Check it out: buff.ly/3VPirtn

👉👉👉Proud to highlight our world-class Leukemia Fellowship, featuring wonderful clinical + research opportunities!!! Dedicated program with alums from all over the 🌍. Led by Dr G Garcia-Manero & Dr Tapan Kadia | Chair Dept of Leukemia 👉 Hagop Kantarjian,MD mdanderson.org/education-trai…

It is with deep sorrow that we bid our brother Emmanuel Almanza-Huante farewell today. A brilliant leukemia physician MD Anderson Cancer Center whose light shone so bright; the world is so much darker now. Please donate to help his family, whom he supported, with costs: gofund.me/f8e20f32

🥳 Double Congratulations Julie Braish Leukemia Chief Fellow from MD Anderson Cancer Center ✅ Poster presentations at #ASH24 ✅ Hem-Onc fellowship at Moffitt Cancer Center Looking forward to seeing your great work & publications as always 👌

📢 Big Congratulations to Julie Braish; Superstar leukemia fellow and Chief fellow MD Anderson Cancer Center! It has been an absolute pleasure to mentor you!!! Fellow to be Moffitt Cancer Center 👏Abstracts at #ASH23, #ASH24, #ASCO24, #MPNBrooklyn 👏👏. Can't wait to see what is coming next 👍👍

Thank you to everyone who attended the 2nd annual HemOnc Pulse Live and contributing valuable insight into unanswered questions in hematologic malignancies. Stay tuned for podcasts coming soon! buff.ly/4mNbrlp Saad Z. Usmani MD MBA FACP 🇺🇸🇵🇰 Mehdi Hamadani, MD Naval Daver, M.D. Sanam Loghavi, MD صنم لغوی 🔬🧬

At the second annual #HOPLive, Julie Braish, a third-year fellow in the Leukemia Fellowship Program at MD Anderson Cancer Center, presented efficacy and safety data on azacitidine plus venetoclax in high-risk #MDS and #CMML. 💡 Learn more: buff.ly/gZrTywe

Our May 2025 print issue is out now!! 🎉 This jam-packed issue includes a feature on diet and blood cancer risk, a Get to Know interview with Kerry Rogers, a fellows spotlight on Julie Braish and Sankalp Arora, MD, and much more. 📚 Don't miss it! buff.ly/Pv6vgNz